These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 1964579
1. Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle. Endoh M, Satoh H, Norota I, Hirano K. Cardiovasc Drugs Ther; 1990 Aug; 4(4):1127-34. PubMed ID: 1964579 [Abstract] [Full Text] [Related]
2. Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle. Satoh H, Endoh M. Jpn J Pharmacol; 1990 Feb; 52(2):215-24. PubMed ID: 2156096 [Abstract] [Full Text] [Related]
3. Subcellular mechanism of the positive inotropic effect of a new quinolinone derivative OPC-8490 on the dog ventricular myocardium. Endoh M, Satoh H, Norota I, Hirano K, Hosokawa T. Heart Vessels; 1991 Feb; 6(3):158-67. PubMed ID: 1655692 [Abstract] [Full Text] [Related]
6. Cardiovascular responses to a newly developed cardiotonic agent, ZSY-39 [4-methyl-5-(4-pyridinyl)-thiazole-2-carboxyamide] in dog cross-circulated atrial and ventricular preparations. Chiba S, Furukawa Y, Saegusa K, Ogiwara Y, Takeda M. Jpn Heart J; 1987 Mar; 28(2):253-60. PubMed ID: 3599412 [Abstract] [Full Text] [Related]
8. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Endoh M, Yanagisawa T, Taira N, Blinks JR. Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745 [Abstract] [Full Text] [Related]
12. Effects of a novel cardiotonic agent, Org 9731, on force and aequorin light transients in intact ventricular myocardium of the dog: involvement of a cyclic AMP-mediated mechanism and myofibrillar responsiveness to Ca2+ ions. Kawabata Y, Endoh M. J Card Fail; 1995 Mar; 1(2):143-53. PubMed ID: 9420644 [Abstract] [Full Text] [Related]
13. Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism. Endoh M. Basic Res Cardiol; 1989 Mar; 84 Suppl 1():69-83. PubMed ID: 2554874 [Abstract] [Full Text] [Related]
14. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043. Endoh M, Yanagisawa T, Morita T, Taira N. J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507 [Abstract] [Full Text] [Related]
16. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine. Katano Y, Endoh M. J Cardiovasc Pharmacol; 1992 Jul; 20(5):715-22. PubMed ID: 1280732 [Abstract] [Full Text] [Related]
18. Muscarinic receptor stimulation and cyclic AMP-dependent effects in guinea-pig ventricular myocardium. Schmied R, Korth M. Br J Pharmacol; 1990 Feb; 99(2):401-7. PubMed ID: 1691677 [Abstract] [Full Text] [Related]
19. Dissociation of cyclic AMP and contractile responses to isoprenaline: effects of a dihydropyridine derivative, nicardipine (YC-93), on canine ventricular muscle. Endoh M, Yanagisawa T, Taira N. Eur J Pharmacol; 1980 Oct 17; 67(2-3):225-33. PubMed ID: 6257529 [Abstract] [Full Text] [Related]
20. Cardiotonic activity of 5-methyl-6-(4-pyridyl)-2H-1,4-thiazin-3(4H)-one hydrochloride (ZSY-27). Yoshioka K, Hino M, Yoshimura A, Yamazaki H, Takase M, Ono H. J Pharmacobiodyn; 1988 Nov 17; 11(11):715-21. PubMed ID: 3236203 [Abstract] [Full Text] [Related] Page: [Next] [New Search]